HomeCompareMTP vs MRK

MTP vs MRK: Dividend Comparison 2026

MTP yields 701.51% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTP wins by $924938.14M in total portfolio value
10 years
MTP
MTP
● Live price
701.51%
Share price
$0.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$924938.20M
Annual income
$722,372,390,440.71
Full MTP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MTP vs MRK

📍 MTP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTP
Annual income on $10K today (after 15% tax)
$59,628.20/yr
After 10yr DRIP, annual income (after tax)
$614,016,531,874.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MTP beats the other by $614,016,523,546.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTP + MRK for your $10,000?

MTP: 50%MRK: 50%
100% MRK50/50100% MTP
Portfolio after 10yr
$462469.13M
Annual income
$361,186,200,119.42/yr
Blended yield
78.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MTP
No analyst data
Altman Z
-17.1
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTP buys
0
MRK buys
0
No recent congressional trades found for MTP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTPMRK
Forward yield701.51%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$924938.20M$56.8K
Annual income after 10y$722,372,390,440.71$9,798.13
Total dividends collected$908543.22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MTP vs MRK ($10,000, DRIP)

YearMTP PortfolioMTP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$80,851$70,150.82$11,206$366.19+$69.6KMTP
2$616,581$530,070.28$12,650$502.35+$603.9KMTP
3$4,437,682$3,777,940.56$14,407$694.19+$4.42MMTP
4$30,160,247$25,411,927.64$16,585$967.82+$30.14MMTP
5$193,682,255$161,410,790.66$19,342$1,363.89+$193.66MMTP
6$1,175,972,185$968,732,172.36$22,913$1,947.19+$1175.95MMTP
7$6,755,308,275$5,497,018,037.06$27,662$2,823.89+$6755.28MMTP
8$36,739,695,007$29,511,515,151.87$34,159$4,173.35+$36739.66MMTP
9$189,313,837,689$150,002,364,032.24$43,337$6,308.80+$189313.79MMTP
10$924,938,196,768$722,372,390,440.71$56,776$9,798.13+$924938.14MMTP

MTP vs MRK: Complete Analysis 2026

MTPStock

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Full MTP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MTP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTP vs SCHDMTP vs JEPIMTP vs OMTP vs KOMTP vs MAINMTP vs JNJMTP vs ABBVMTP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.